News

The organizations set out 3 recommendations for initial and recurrent C diff treatment.

An interview with a study author on new Novavax-Seqirus co-administration trial data, and the future concerns of circulating COIVD-19 and influenza.

Delta Plus is very similar to the Delta variant with 1 additional mutation.

With a small number of heart-related adverse effects in younger people, the US Food and Drug Administration (FDA) will move towards a warning statement for Pfizer and Moderna vaccines.

More treatment options and modalities are now available for patients.

A new report from a Qatari pilot program showed vaccines are highly effective against COVID-19, but they do not completely eliminate risk.

The benefits of mRNA vaccinations were determined to still clearly outweigh the risks in adolescents and young adults.

New ASM data show indoor environments are associated with quick and frequent pathogen contamination of the common respiratory device.

Because the number of children hospitalized with COVID-19 is so low, facilities should ensure clinical data is easily available and shared across healthcare platforms.

Children infected with SARS-CoV-2 who are Black, Hispanic or Asian have a greater risk of developing the rare multisystem inflammatory syndrome, a new study found.

The device may help clinicians differentiate between past infections and co-infections during the upcoming flu season.

Greater disease severity was associated with low executive functioning.

According to a small study, the Moderna and Pfizer COVID-19 vaccines do not impact male fertility.

Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.

The course of COVID-19 illness was likely to be less severe than of influenza in a study of hospitalized children.

New findings on an available 15-minute test show an approximate 81% sensitivity in detection of SARS-CoV-2.

New findings from the ASM 2021 World Microbe Forum suggest the emergency-authorized platform can capably detected the highly transmissible UK-borne variant.

Investigators looked at data from 3 analyses showed a reduction in mortality was observed across a spectrum of baseline oxygen requirements, at different timeframes, over the course of the pandemic, and in various geographies.

Africa sees third wave as only 1% of the population is fully vaccinated.

The recombinant human IgG1κ monoclonal antibody binds and neutralizes the virus.

A study paired long-term care facilities (LTCF) staff who were recovered with susceptible residents to help reduce transmission. The goal was simple: pair those susceptible staff and residents with those who were recovered and felt to have protective immunity.

EUAs can enable people to get immediate access to preventive therapy or treatment, but is it always worth aiming for full approval?

Modeling studies highlight best approaches for schools in the coming academic year.

QPX9003 was developed through an NIAID-supported drug discovery collaboration with world experts.

CVnCoV demonstrated an interim vaccine efficacy of 47% against COVID-19 disease of any severity.

Investigators in Brazil attribute Trichosporon asahii fungemia in critically ill COVID-19 patients to “overexposure” to antibiotics and corticosteroids.

A discussion surrounding Novavax’s NVX-CoV2373 with Lisa Dunkle, MD.